McAdam LLC’s Aptus Defined Risk ETF DRSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,122
Closed -$202K 262
2023
Q2
$202K Sell
8,122
-5,670
-41% -$144K 0.02% 252
2023
Q1
$358K Buy
+13,792
New +$357K 0.03% 178
2022
Q4
Sell
-12,222
Closed -$310K 199
2022
Q3
$310K Buy
12,222
+21
+0.2% +$558 0.03% 161
2022
Q2
$321K Buy
+12,201
New +$329K 0.03% 164

Other funds holding DRSK

McAdam LLC's DRSK Position: Q3 2023 in Review

McAdam LLC sold out of Aptus Defined Risk ETF (DRSK) in Q3 2023, closing a stake of 8,122 shares — an estimated $202K sold.

McAdam LLC first reported a position in DRSK in Q2 2022 and held it in 4 quarters. The position peaked at $358K in Q1 2023. 46 funds tracked by Wall St. Rank hold DRSK as of Q3 2023.

  • McAdam LLC reported no remaining Aptus Defined Risk ETF position as of Q3 2023 after selling out during the quarter.
  • McAdam LLC sold 8,122 Aptus Defined Risk ETF shares in Q3 2023, an estimated $202K.
  • McAdam LLC first reported a position in Aptus Defined Risk ETF in Q2 2022 and held it in 4 quarters.
  • McAdam LLC's Aptus Defined Risk ETF position peaked at $358K in Q1 2023.
  • 46 funds tracked by Wall St. Rank held Aptus Defined Risk ETF as of Q3 2023.

Based on McAdam LLC's 13F filing for Q3 2023, filed 31 Oct 2023.